日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of SLE among "potential SLE" patients seen in consultation: long-term follow-up

门诊就诊的“疑似SLE”患者中SLE的发生发展:长期随访

Al Daabil, M; Massarotti, E M; Fine, A; Tsao, H; Ho, P; Schur, P H; Bermas, B L; Costenbader, K H

Clinical manifestations and survival among adults with (SLE) according to age at diagnosis

根据诊断年龄分析成人系统性红斑狼疮(SLE)的临床表现和生存情况

Merola, J F; Bermas, B; Lu, B; Karlson, E W; Massarotti, E; Schur, P H; Costenbader, K H

Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis

抗环瓜氨酸肽 类风湿性关节炎分类修订标准

Liao, K P; Batra, K L; Chibnik, L; Schur, P H; Costenbader, K H

Antibodies to C reactive protein.

C反应蛋白抗体

Rosenau B J, Schur P H

Clinical utility of the anti-CCP assay in patients with rheumatic diseases

抗CCP检测在风湿病患者中的临床应用价值

Lee, D M; Schur, P H

Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus

在系统性红斑狼疮患者中,应激诱导细胞凋亡过程中磷酸化的蛋白质是自身抗体产生的常见靶点。

Utz, P J; Hottelet, M; Schur, P H; Anderson, P

Antibodies to T- and L-isoforms of the cytoskeletal protein, fimbrin, in patients with systemic lupus erythematosus

系统性红斑狼疮患者体内针对细胞骨架蛋白纤维蛋白的T型和L型亚型的抗体

De Mendonca Neto, E C; Kumar, A; Shadick, N A; Michon, A M; Matsudaira, P; Eaton, R B; Kumar, P; Schur, P H

Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus

T细胞受体限制性片段长度多态性与系统性红斑狼疮的关联

Tebib, J G; Alcocer-Varela, J; Alarcon-Segovia, D; Schur, P H

Z-DNA-specific antibodies in human systemic lupus erythematosus

人类系统性红斑狼疮中的Z-DNA特异性抗体

Lafer, E M; Valle, R P; Möller, A; Nordheim, A; Schur, P H; Rich, A; Stollar, B D

Complement-human histocompatibility antigen haplotypes in C2 deficiency

C2缺陷中的补体-人类组织相容性抗原单倍型

Awdeh, Z L; Raum, D D; Glass, D; Agnello, V; Schur, P H; Johnston, R B Jr; Gelfand, E W; Ballow, M; Yunis, E; Alper, C A